US No Surprises Act (42 USC 300gg-111 to 300gg-139) and 45 CFR Part 149
Plan and issuer duties: patient protections, continuity, directories, gag clauses and reporting (45 CFR 149.310, 149.530, 149.710 to 149.740; 42 U.S.C. 300gg-113 to 300gg-120) – US No Surprises Act (42 USC 300gg-111 to 300gg-139) and 45 CFR Part 149

US No Surprises Act (42 USC 300gg-111 to 300gg-139) and 45 CFR Part 149 149.720-730: File the annual prescription drug and health care spending (RxDC) report by 1 June for the prior reference year, aggregated by State and market segment

Each plan and issuer (church plans excepted by the statute) must submit annually to HHS, Treasury and Labor, by 1 June for the preceding reference year, the prescription drug and health care spending report in the form and manner prescribed, separately for each State in which coverage was provided and for each market segment, with the experience of all plans and policies in the State. An issuer acquiring a block of business reports for the whole reference year; a plan may rely on a written agreement with its issuer, pharmacy benefit manager, TPA or other party to report on its behalf, but remains liable if a non-issuer contracted party fails to report; multiple reporting entities may not aggregate at a less granular level than the entity reporting total spending.

Maintained by Gerard Blokdyk

Other controls in Plan and issuer duties: patient protections, continuity, directories, gag clauses and reporting (45 CFR 149.310, 149.530, 149.710 to 149.740; 42 U.S.C. 300gg-113 to 300gg-120) – US No Surprises Act (42 USC 300gg-111 to 300gg-139) and 45 CFR Part 149

Query this from an agent

The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.